Previous studies have shown that RIPK2 might be responsible for the chronic inflammation of inflammatory bowel disease (IBD) [28, 29], and the high level of RIPK2 expression was associated with advanced tumors and metastasis of inflammatory breast cancer [30]. This evidence concerns the gene RIPK2 and inflammatory breast carcinoma.